The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults
Abstract
Background— There is evidence from recent studies that γ-glutamyltransferase (GGT) is likely to be associated with cardiovascular disease (CVD). However, few studies to date with sufficient sample size and follow-up investigated the association of GGT with CVD mortality. Methods and Results— The relation of GGT to the risk of death from CVD was examined in a cohort of 163 944 Austrian adults that was monitored for up to 17 years. To evaluate GGT as an independent predictor, Cox proportional hazards models were calculated, which adjusted for established risk factors. In both men and women, high GGT was significantly ( P <0.001) associated with total mortality from CVD, showing a clear dose-response relationship. Adjusted hazard ratios (95% CI) per log GGT increase were 1.66 (1.40 to 1.98) in men and 1.64 (1.36 to 1.97) in women. In men, subgroup analyses showed that high GGT was positively associated with incident fatal events of chronic forms of coronary heart disease ( P =0.009), congestive heart failure ( P <0.001), and hemorrhagic ( P =0.01) and ischemic stroke ( P <0.001). No significant associations were observed for acute myocardial infarction ( P =0.16). In women, hazard ratios suggested associations in all subgroups; however, for hemorrhagic and ischemic stroke they were not statistically significant ( P =0.09 and P =0.07, respectively). In addition, subgroup analyses stratified by age revealed a stronger relationship of GGT in younger participants. Hazard ratios for total CVD were 2.03 (1.53 to 2.69) in men and 2.60 (1.53 to 4.42) in women younger than 60 years. Conclusions— This study demonstrates in a large, prospectively observed cohort that GGT is independently associated with cardiovascular mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Whitfield, J. B. (2001) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/20014091084227 · Cited by 1,153
Langer, R. D., Criqui, M. H., & Reed, D. M. (1992) · Circulation · doi:10.1161/01.cir.85.3.910 · Cited by 384
Wannamethee, G., Ebrahim, S., & Gerald Shaper, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117699 · Cited by 334
De Oliveira e Silva, E. R., Foster, D., McGee Harper, M., Seidman, C. E., Smith, J. D., Breslow, J. L., & Brinton, E. A. (2000) · Circulation · doi:10.1161/01.cir.102.19.2347 · Cited by 321
Isolation of metabolically active capillaries from rat brain1,2
Goldstein, G. W., Wolinsky, J. S., Csejtey, J., & Diamond, I. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb04395.x · Cited by 319
Nakanishi, N., Suzuki, K., & Tatara, K. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1427 · Cited by 304
Alcohol Consumption and Hemostatic Factors: Analysis of the Framingham Offspring Cohort
Mukamal, K. J., Jadhav, P. P., D’Agostino, R. B., Massaro, J. M., Mittleman, M. A., Lipinska, I., Sutherland, P. A., Matheney, T., Levy, D., Wilson, P. W. F., et al. (2001) · Circulation · doi:10.1161/hc3701.096067 · Cited by 248
Moderate Alcohol Consumption and the Risk of Sudden Cardiac Death Among US Male Physicians
Albert, C. M., Manson, J. E., Cook, N. R., Ajani, U. A., Gaziano, J. M., & Hennekens, C. H. (1999) · Circulation · doi:10.1161/01.cir.100.9.944 · Cited by 208
Cited by
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Targher, G., & Arcaro, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
A wellness study of 108 individuals using personal, dense, dynamic data clouds
Price, N. D., Magis, A. T., Earls, J. C., Glusman, G., Levy, R., Lausted, C., McDonald, D. T., Kusebauch, U., Moss, C. L., Zhou, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3870 · Cited by 427
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Targher, G., Marra, F., & Marchesini, G. (2008) · Diabetologia · doi:10.1007/s00125-008-1135-4 · Cited by 378
Ruhl, C. E., & Everhart, J. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 352
Cardiohepatic Interactions in Heart Failure
Samsky, M. D., Patel, C. B., DeWald, T. A., Smith, A. D., Felker, G. M., Rogers, J. G., & Hernandez, A. F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.042 · Cited by 341
Koenig, G., & Seneff, S. (2015) · Disease Markers · doi:10.1155/2015/818570 · Cited by 331
Emdin, M., Pompella, A., & Paolicchi, A. (2005) · Circulation · doi:10.1161/circulationaha.105.571919 · Cited by 315
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 277
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J.-J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 267
Fabbrini, E., Mohammed, B. S., Korenblat, K. M., Magkos, F., McCrea, J., Patterson, B. W., & Klein, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2622 · Cited by 192
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Huang, R.-C., Mori, T. A., Burke, V., Newnham, J., Stanley, F. J., Landau, L. I., Kendall, G. E., Oddy, W. H., & Beilin, L. J. (2009) · Diabetes Care · doi:10.2337/dc08-1917 · Cited by 93
Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., Gray, S. R., Forrest, E., Alazawi, W., Gill, J. M., Katikireddi, S. V., Cleland, J. G., Welsh, P., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101435 · Cited by 41
Metadata
- Authors
- Ruttmann, E., Brant, L. J., Concin, H., Diem, G., Rapp, K., Ulmer, H., & the Vorarlberg Health Monitoring and Promotion Program Study Group
- Venue
- Circulation
- Published
- 2005-10-04
- Volume
- 112
- Issue
- 14
- Pages
- 2130-2137
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2127510700
- Cited by
- 556
- References
- 31
- FWCI
- 18.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.